Telomir Pharmaceuticals Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Telomir Pharmaceuticals Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Florida
Headquarters city: Miami
Headquarters state / province: Florida
Headquarters country: United States
Fiscal year end: December
Ticker symbol: TELO
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001971532
EIN: 87-2606031

Board of directors

Follow this board

Bradley Kroenig · Director
Since 2024
Christopher C. Chapman Jr. · Director · CEO & Chairman
Since 2024
Christos Nicholoudis · Director · General Counsel
Since 2024
Craig Eagle · Director
Since 2024
Edward Clouston MacPherson · Director
Since 2024
Erez Aminov · Director · CEO and Chairman
Since 2024
Giudice Matthew Paul Del · Director
Since 2024
Hugh McColl III · Director
Since 2024
Matthew Pratt Whalen · Director
Since 2024
Michael Allen Jerman · Director
Since 2024
Talhia Tuck · Director
Since 2024

Chief executives

Erez Aminov · CEO & Chairman

Since August 2024

Christopher C. Chapman Jr. · CEO & Chairman

2024 – 2024 · Former

Board connections

11 of this board's directors also sit on 5 other boards. 4 are in the same sector.

Shared director Other board Same sector

MIRA Pharmaceuticals Inc. Same sector
via Bradley Kroenig, Christopher C. Chapman Jr., Christos Nicholoudis, Edward Clouston MacPherson, Erez Aminov, Giudice Matthew Paul Del, Hugh McColl III, Matthew Pratt Whalen, Michael Allen Jerman and Talhia Tuck
Q/C Technologies Inc. Same sector
via Christopher C. Chapman Jr. and Craig Eagle
Alaunos Therapeutics Inc. Same sector
via Michael Allen Jerman
OS Therapies Incorporated Same sector
via Craig Eagle
Westrock Coffee Company
via Hugh McColl III

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Apr 22, 2026	Erez Aminov Director, Officer (CEO and Chairman)	Other	+7,319,710	$1.37	$10,028,003
Aug 19, 2024	Erez Aminov Director, Officer (CEO and Chairman)	Open-market sale	−200	$6.01	$1,202
Aug 19, 2024	Erez Aminov Director, Officer (CEO and Chairman)	Open-market sale	−200	$6.20	$1,240
Feb 13, 2024	McNulty Brian Patrick 10% owner	Open-market purchase	+49,000	$7.00	$343,000
Feb 13, 2024	McNulty Brian Patrick 10% owner	Open-market purchase	+40,000	$7.00	$280,000
Feb 13, 2024	McNulty Brian Patrick 10% owner	Open-market purchase	+49,000	$7.00	$343,000

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Telomir Pharmaceuticals Inc.

Who is the CEO of Telomir Pharmaceuticals Inc.?

Erez Aminov has been Telomir Pharmaceuticals Inc.'s CEO & Chairman since August 2024.

How many directors are on Telomir Pharmaceuticals Inc.'s board?

Telomir Pharmaceuticals Inc.'s board has 11 directors: Bradley Kroenig, Christopher C. Chapman Jr., Christos Nicholoudis, Craig Eagle, Edward Clouston MacPherson, Erez Aminov, Giudice Matthew Paul Del, Hugh McColl III, Matthew Pratt Whalen, Michael Allen Jerman and 1 other.

How is Telomir Pharmaceuticals Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="telomir-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.